Clinical Trial Update: A Study of MHB036C for Advanced Solid Tumor [Phase 1, Phase 2]

View source ↗

Summary

This update describes a Phase 1/Phase 2 study of the experimental cancer therapy MHB036C for advanced solid tumors, with the trial currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• MHB036C

Snippet

Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd | Conditions: Advanced Solid Tumor | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING